Biotechnology News

March 12, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX announced its expansion of commercial operations in Brazil.

March 12, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Present at the 24th Annual ROTH Conference

March 12, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Identifies Promising New Business Targets at Texas’ Premiere Life Sciences Forum

March 12, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (OMX Nordic Exchange: AERO) announces that United Healthcare has retired its negative coverage policy effective April 1, 2012. Aerocrine received notification late afternoon on Friday...

March 12, 2012

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd (TASE:MZOR), the leader in innovative surgical robots and complementary products for spine surgery, signed an agreement with Cicel Science & Technology Co., Ltd. to distribute its...

March 12, 2012

NORTHRIDGE, Calif. & CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--AVITA MEDICAL COMMENCES TRADING ON THE US OTCQX INTERNATIONAL EXCHANGE TRADING UNDER SYMBOL AVMXY

March 12, 2012

SINGAPORE--(BUSINESS WIRE)--Inviragen's Hand, Foot and Mouth Disease vaccine generated immune responses in 100% of Phase 1 study participants. HFMD is a significant problem in Asia, affecting approximately 2M children annually.

March 9, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. to Report 2011 Fourth Quarter and Year-End Financial Results on March 13

March 9, 2012

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Sientra receives FDA approval of its portfolio of Silimed-brand round and shaped silicone breast implants.

March 9, 2012

HARTFORD, Conn.--(BUSINESS WIRE)--Dr Edmund Pezalla, National Medical Director for Pharmaceutical Policy and Strategy for Aetna Pharmacy Management,presenting at 2012 World Biomarkers Consortium on March 11 in Orlando, Florida

March 9, 2012

HORSHAM, England--(BUSINESS WIRE)--Cmed Clinical Services Invited to Speak at Leading Industry Events

March 9, 2012

MIAMI & JUPITER, Fla.--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE: OPK) and The Scripps Research Institute today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from...

March 9, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and commercializing products to treat medical conditions in inflammatory, cardiovascular, orthopedic, and wound healing...

March 9, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the appointment of Jane E. Henney, M.D. to its Board of Directors. Dr. Henney currently is a Professor of Medicine at the University of Cincinnati...

March 9, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the Barclays Capital 2012 Global Healthcare Conference will be webcast and may be accessed at...

March 9, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, BioSante’s president & CEO will present a corporate update at the Roth Health Care Conference to be held at Ritz Carlton...

March 9, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Not for release, or for publication or distribution, directly or indirectly in or into the United States, Australia, Hong Kong, Canada, Japan, New Zeeland or South Africa. Today’s extraordinary...

March 9, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announced that on March 7, 2012, the Food and Drug Administration (“FDA”) denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with...

March 8, 2012

OAKWOOD VILLAGE, Ohio--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it will provide real-world training in radiation detection and measurement to nuclear safety professionals within the...

March 8, 2012

SEATTLE--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced full results from the second pivotal Phase 3 clinical trial (Study 103) of its Quad once-daily single tablet regimen of elvitegravir, cobicistat, emtricitabine and...

March 8, 2012

WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement applauding Senate passage last night of the Pandemic All-Hazards Preparedness Act (PAHPA) Reauthorization of...

March 8, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex:BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Financial Officer, Peter S. Garcia, will present a...

March 8, 2012

BEIJING--(BUSINESS WIRE)--The Prostate Cancer Foundation today announced its first two Young Investigators in China to launch its initiative to identify, fund and promote innovative research projects within China. As with all of its funded...

March 8, 2012

FORT WASHINGTON, Pa.--(BUSINESS WIRE)--The National Comprehensive Cancer Network® (NCCN®) announces that it has issued new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Adolescent and Young Adult (AYA) Oncology. AYA...

March 8, 2012

DENVER & SHENYANG, China--(BUSINESS WIRE)--DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD) today announced it has entered into an agreement with 3SBio Inc., a leading...

March 8, 2012

SAN MATEO, Calif.--(BUSINESS WIRE)--Maxygen, Inc. (Nasdaq:MAXY), a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011. Fourth Quarter 2011 Financial Results Maxygen reported...

March 8, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today its financial results for the fourth quarter and full year ended December 31, 2011. Total revenues for 2011 were $273.4 million as compared to $286.2 million...

March 8, 2012

JERUSALEM & BOTHELL, Wash. & VANCOUVER, British Columbia--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) and OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today an update on their development program for...

March 8, 2012

NORTHWOOD, Ohio--(BUSINESS WIRE)--NAMSA, a leading medical device research organization, recently announced the opening of its newest office near Frankfurt, Germany. Staff with regulatory and quality expertise, clinical managers, and local...

March 8, 2012

WASHINGTON--(BUSINESS WIRE)--Company executives, scientists and government officials will bring a global perspective as featured presenters at BIO’s 9th annual World Congress on Industrial Biotechnology and Bioprocessing. The world’s largest...

March 8, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) applauds the House on the passage of H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act.

March 8, 2012

HENRIETTA, N.Y.--(BUSINESS WIRE)--SensiVida Medical Technologies Inc. (PINK SHEETS: SVMT) (www.sensividamedical.com) (“SensiVida”), a developer and provider of digital...

March 8, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro submits NDA to the US FDA for corneal cross-linking for keratoconus and post-Lasik ectasia

March 8, 2012

NEWARK, N.J.--(BUSINESS WIRE)--According to the NJ FamilyCare/Medicaid “HMO Performance Report”, Horizon NJ Health received the highest performance score of all New Jersey’s Medicaid managed care plans.

March 8, 2012

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to release new updated photos from the 3rd cancer patient self-administering...

March 8, 2012

SALT LAKE CITY--(BUSINESS WIRE)--Catheter Connections today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application that broadly covers a method of disinfecting IV tubing end...

March 8, 2012

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation Presentation at the Barclays Capital 2012 Global Healthcare Conference to be Webcast Live

March 8, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Canada’s leading national health research and innovation organizations have come together to form Research 7 (R7), an unprecedented partnership to work with Canadian governments to tackle our biggest

March 8, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--SILVER SPRING, MD – Nuvilex, Inc. (OTCQB:NVLX) today discussed use of the company’s cell encapsulation technology with modified stem cells to treat late stage cancers.

March 8, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) (“Alkermes”) today announced the pricing of an underwritten public offering of 21,000,000 ordinary shares held by a subsidiary of Elan Corporation, plc (“Elan”) at a price to the public of $16....

March 8, 2012

NORTH WALES, Pa.--(BUSINESS WIRE)--Teva Respiratory announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir® HFA with a dose counter for use in patients 4 years of age and older for the treatment or prevention of...

March 8, 2012

SHANGHAI--(BUSINESS WIRE)--With the launch of China’s 12th Five-year Plan for the biomedical industry, China’s antibody drugs development will usher in a golden era. According to prediction of askci.com, by 2015, China’s antibody drugs industry...

March 8, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced it has completed its acquisition of Avila Therapeutics. Celgene acquired Avila Therapeutics for $350 million in cash, plus up to $575 million contingent upon...

March 8, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2012 second quarter results on Tuesday, March 13, 2012, at 8:30 AM E.T. To listen to the conference call dial 1-888-459-5609. International...

March 8, 2012

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE:COV), a leading global provider of healthcare products, today announced the opening of four research and development (R&D) centers. The R&D facilities are located in: Boulder, Colorado;...

March 8, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Moves Forward on Term Sheet with Parkinson’s Drug Therapy Target

March 8, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)--LifeSciences BC is pleased to announce the recipients of the 2012 LifeSciences British Columbia Awards. They are: Genome BC Award for Scientific Excellence   Dr. Neil Cashman, Professor and Canada...

March 8, 2012

WASHINGTON--(BUSINESS WIRE)--AHF files ‘citizen’s petition’ with FDA to ‘delay or deny’ approval of Gilead’s HIV ‘prevention’ pill -- DC Press Conference, Thursday, March 8th, National Press Club (Washington), 12:30 pm.

March 7, 2012

SAN JOSE, Calif.--(BUSINESS WIRE)--Stratedigm announces the commercial launch of its A600 High Throughput Auto Sampler (HTAS). The A600 HTAS compliments the company’s existing line of analyzers which range from the entry level two laser, eight...